Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.
Related Posts
-
Eurobites: Nokia teams up with Rohde & Schwarz to boost 6G coverage
Also in today’s EMEA regional roundup: Orange builds cable ships; Giffgaff hires former News Corp…
-
Harmonic scores a bigger piece of Charter’s network upgrade
Under an expanded partnership that will set up an improved 2026 for Harmonic, the supplier…
-
NTT Docomo net drops in heated mobile market
NTT Docomo hikes capex 38% as it fights for market share, while its Q3 earnings…
-
Government shutdown ties for longest in US history amid stalled negotiations
The ongoing government shutdown has reached a historic length, with limited dialogue between Democrats and…
Leave a Reply